Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

263
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
263
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

233
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
233
Tissue Transplantation01:24

Tissue Transplantation

810
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
810
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

737
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
737
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

263
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
263

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcomes of Renal Transplant Allografts With De Novo DSA in the Setting of Stable Function.

Clinical transplantation·2026
Same author

Graft survival after liver transplantation using portable normothermic machine perfusion at a US center.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Evaluating the impact of neighborhood socioenvironmental burden on patient characteristics and survival in liver transplant recipients.

Frontiers in transplantation·2026
Same author

Cell cycle pathway alterations predict outcomes post-liver transplantation for hepatocellular carcinoma.

Frontiers in transplantation·2026
Same author

Liver transplantation in patients with history of extra-hepatic malignancies.

Frontiers in transplantation·2026
Same author

Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center.

The Journal of surgical research·2026

Related Experiment Video

Updated: Dec 25, 2025

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

745

Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.

Kyle R Jackson1, Jane Long1, Jennifer Motter1

  • 1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Transplantation
|April 3, 2020
PubMed
Summary

Center practices for HLA-incompatible living donor kidney transplantation (ILDKT) show minimal variation in patient outcomes. This study suggests continued ILDKT practice across diverse transplant centers is supported.

More Related Videos

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.5K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.8K

Related Experiment Videos

Last Updated: Dec 25, 2025

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

745
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.5K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.8K

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Clinical Outcomes Research

Background:

  • Desensitization protocols for HLA-incompatible living donor kidney transplantation (ILDKT) differ significantly among medical centers.
  • The impact of these protocol variations and other practice differences on ILDKT outcomes is not well understood.

Purpose of the Study:

  • To assess center-level variations in mortality and graft loss after ILDKT.
  • To identify center-specific characteristics associated with better ILDKT outcomes.

Main Methods:

  • A cohort of 1358 ILDKT recipients from 25 centers was analyzed.
  • Multilevel Cox regression with shared frailty was used to quantify between-center outcome variation.
  • Data were linked to the Scientific Registry of Transplant Recipients for accurate outcome tracking.

Main Results:

  • After adjusting for patient factors, significant between-center variation in mortality and graft loss was minimal (4.7% and 4.4%, respectively).
  • A median hazard ratio of 1.36 for mortality and 1.34 for graft loss indicated similar candidates had different outcomes at different centers.
  • Center characteristics like ILDKT volume or patient demographics did not correlate with improved outcomes.

Conclusions:

  • Substantial center-level variation in outcomes was not observed for ILDKT, contrasting with other transplant areas.
  • The findings support the ongoing practice of ILDKT across a variety of transplant centers.